August 6 is one of the heaviest earnings days of the season. More than 30 S&P 500 companies posted results, and guidance upgrades are the dominant theme.
Cloudflare raised its full-year sales outlook to $2.864–$2.870B. That tops the prior $2.813B estimate. Q3 guidance also cleared consensus comfortably. JFrog followed suit, lifting FY2026 sales guidance to $648–$652M from $628–$632M. Both cloud software names are rewarding bulls who held through a tough year.
FIGS delivered one of the session's sharpest guidance jumps. The healthcare apparel brand raised FY2026 sales guidance to $757M — well above the $729M estimate. ResMed also boosted its dividend, raising the quarterly payment from $0.60 to $0.66 per share.
Energy names ConocoPhillips and Occidental Petroleum both reported today, offering a key read on sector health. also posted results as nuclear power demand from data centres stays firmly in focus.
indie Semiconductor hit an extreme setup today. Utilization reached 100% and availability collapsed to 0%. Short interest sits at 35% of free float. New short positions are effectively impossible to open. Squeeze risk is acute.
Hertz shows similar dynamics. Availability has dried to zero with short interest at 82% of free float. Covering continues as borrowable supply disappears.
Insulet was cut to Market Perform by Leerink Partners today. The price target dropped to $145. Healthcare names also saw Boston Scientific CEO Michael Mahoney file a $9M purchase — a notable vote of confidence from the top.
Charles Schwab's founder filed over $35M in sales this week. Carlos Slim Helu reported a $36.6M exit from PBF Energy. Both are among the largest insider sell filings of the month.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
